MedCap-backed Unimedic completed the acquisition of XGX  Pharma.

MedCap-backed Unimedic, a fully integrated Swedish specialty pharma company, completed the acquisition of XGX  Pharma, a Denmark‑based specialty pharmaceutical company. Financial terms were not disclosed. "We are thrilled to welcome XGX to Unimedic. The acquisition aligns with our long-term strategy to become a leading specialty pharma company in the Nordics and enables us to support more patients across a wider range of therapeutic areas," Johan Frödin, Unimedic CEO.